miRecule
  • Home
  • Technology Platform
  • Programs
  • Team
  • News
  • Contact
Select Page

miRecule interviewed in the Washington Business Journal!

by Ashwin Kulkarni | Dec 16, 2020 | Uncategorized

Anthony Saleh’s biotech, miRecule, is using microRNA therapeutics to treat cancers. This seed round will send the startup into the next phase of its journey toward clinical trials. – Washington Business Journal

miRecule published in Clinical Cancer Research!

by Ashwin Kulkarni | Dec 16, 2020 | Uncategorized

Integrated genomic and functional microRNA analysis identifies miR-30-5p as a tumor suppressor and potential therapeutic nanomedicine in head and neck cancer – Clinical Cancer Research

miRecule featured by the BioHealth Capital Region Investment Conference!

by Ashwin Kulkarni | Dec 16, 2020 | Uncategorized

miRecule closes Seed Round at the second annual BioHealth Capital Region Investment Conference  – BioBuzz

miRecule featured by the FSHD Society!

by Ashwin Kulkarni | Dec 16, 2020 | Uncategorized

miRecule, Inc., is developing a novel treatment for FSHD – FSHD Society

miRecule awarded grant by Friends of FSH Research!

by Ashwin Kulkarni | Dec 16, 2020 | Uncategorized

Antisense Oligonucleotide-Antibody Conjugates to Treat FSHD – Friends of FSH Research
« Older Entries

miRecule, Inc.
704 Quince Orchard Road
Gaithersburg, MD 20878

  • Follow
  • Follow